NCT07018427 2025-06-12
Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
Peking University Cancer Hospital & Institute
Active not recruiting
Clinical Trials
5 trialsNCT06793306 2025-02-14
A Study Comparing the Differences Between Young and Non-young Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Enrolling by invitation
NCT05228951 2022-09-13
Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC
Shengjing Hospital
Phase 2 Recruiting
NCT04486911 2022-08-02
Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II Trial
Shengjing Hospital
Phase 2 Active not recruiting
NCT02165696 2014-06-17
LYMPHATIC
University of Malaga
Phase NA Unknown